Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2011-07-15 Regulatory Filings
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
NEW HEADQUARTERS OFFICE SPACE LEASE
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 15, 2011. It reports the entry into a material definitive agreement, specifically a lease for new headquarters office space. The lease is with a related party (Chairman of the Board). The document does not contain financial statements or detailed financial data but is an announcement of a significant corporate event. It is not an annual or quarterly report, audit report, earnings release, or any other detailed financial or management report. It fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit into more specific categories.
2011-07-15 English
CURRENT REPORT FAIRMOUNT FIVE JULY 2011 TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 11, 2011. It reports an unregistered sale of equity securities (Convertible Preferred Shares) by the company Ecology Coatings, Inc. The content focuses on a financing transaction involving the purchase of preferred shares and details about the securities, including liquidation preference, conversion price, and dividend rate. There are no financial statements or comprehensive financial data included, and the document is relatively short (3230 characters). This type of filing is an update on capital structure and financing activities rather than a full financial report or earnings release. Therefore, it fits best under the category Capital/Financing Update (CAP).
2011-07-11 English
FIRST AMENDMENT KROTINE EMPLOYMENT AGREEMENT
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 6, 2011. It announces an amendment to an employment agreement increasing the annual salary of an executive. The content focuses on a material definitive agreement related to management compensation. There are no financial statements or detailed financial data presented, nor is it a full annual or quarterly report. It is not a proxy, voting result, or legal proceeding. The document is primarily about a management agreement change, which fits best under Board/Management Information (MANG). The document length is short and it is a standalone announcement, not a report publication or certification. Therefore, the classification is MANG with high confidence.
2011-06-06 English
FORM 4
Director's Dealing
2011-05-25 English
AMENDMENT OF RAMSEY'S EMPLOYMENT AGREEMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A, which is a current report filed with the SEC to disclose material events. The content specifically details an amendment to an employment agreement for a named executive, increasing the annual salary. There are no financial statements or comprehensive financial data presented, nor is this an annual or quarterly report. The document is not a call transcript, earnings release, or any form of investor presentation. It is a regulatory filing disclosing a material event related to management employment terms. Given the nature of the content and the form type, this fits best under Regulatory Filings (RNS). The document length is short and focused on a specific event, consistent with RNS filings.
2011-05-19 English
RAMSEY THIRD AMENDMENT EMPLOYMENT AGREEMENT
Board/Management Information Classification · 95% confidence The document is titled 'Third Amendment to Employment Agreement' and details an amendment to the employment terms of an executive, specifically salary adjustment. It is a formal announcement of a change in employment terms rather than a full report or financial statement. There is no financial data, no regulatory certification, or report publication. This fits the category of Board/Management Information (MANG), which includes announcements of changes in senior management or their employment terms.
2011-05-19 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.